Daiichi Sankyo, GENESIS Pharma Agree on VANFLYTA® in CEE
Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13...
Tag : Daiichi Sankyo
ENHERTU® EU Approval: First HER2 Therapy for HR+ Metastatic BC
Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of...